Pharmaceutical Policy Insights from a Former Provincial Minister of Health
Gerry Jeffcott, Provincial Reimbursement Advisor, novembre 2016
Canadian Orphan Drug Policies: Moving Forward, Slowly
Johanne Chambers et Bill Dempster, Provincial Reimbursement Advisor, novembre 2016
Companion Diagnostics for Innovative Pharmaceuticals: Facilitators or Obstacles to Market Access?
Rachael Manion et Bill Dempster, Provincial Reimbursement Advisor, août 2016
PharmaFocus 2020
Gerry Jeffcott, Rachael Manion, Alexandra Kyriakos, Bill Dempster et Michel Parent, juin 2016
Ontario Prepares for Public Drug Program Revamp
Alexandra Kyriakos et Bill Dempster, Provincial Reimbursement Advisor, mai 2016
Competing Pressures: Market Growth Versus Provincial Budget Constraints
Gerry Jeffcott, Provincial Reimbursement Advisor, février 2016
A New Federal Government: Sunny Ways or Gloomy Days Ahead for the Pharmaceutical Industry?
Bill Dempster et Johanne Chambers, Provincial Reimbursement Advisor, février 2016
Five Years of the pCPA — Impact and Opportunities for Industry
Johanne Chambers et Bill Dempster, Provincial Reimbursement Advisor, novembre 2015
Canada: The Impact on Drug Reimbursement of Healthcare System Reform in Quebec
Johanne Chambers et Dima Samaha, IMS Pharma Pricing & Reimbursement, septembre 2015, Vol. 20(9)
Therapeutic Reviews: Experience in Canada and Impact on Reimbursement
Johanne Chambers & William Dempster, IMS Pharma Pricing & Reimbursement, septembre 2015, Vol. 19(6)